Over the past 12 months, 0 insiders at Blueprint Medicines Corp filed 0 open-market SEC Form 4 transactions on BPMC: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 3, 25 | Percy H. CarterCHIEF SCIENTIFIC OFFICER | SELL | 1.1K | $128.25 | $135K |
| Jul 3, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 1.2K | $128.25 | $150K |
| Jun 3, 25 | Percy H. CarterCHIEF SCIENTIFIC OFFICER | SELL | 2.4K | $127.88 | $309K |
| May 27, 25 | Jeffrey W. AlbersDirector | SELL | 4.3K | $101.93 | $439K |
| May 19, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 1.4K | $101.72 | $142K |
| May 5, 25 | Ariel HurleyPRINCIPAL ACCOUNTING OFFICER | SELL | 1.4K | $104.78 | $145K |
| May 5, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 1.3K | $103.56 | $137K |
| Apr 1, 25 | Kate HavilandCHIEF EXECUTIVE OFFICER | SELL | 1.2K | $88.59 | $105K |
| Mar 24, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 2.3K | $95.02 | $216K |
| Mar 12, 25 | Jeffrey W. AlbersDirector | SELL | 5.7K | $88.37 | $499K |
| Mar 6, 25 | L. Becker HewesCHIEF MEDICAL OFFICER | SELL | 2.7K | $87.98 | $235K |
| Mar 5, 25 | Jeffrey W. AlbersDirector | SELL | 5.8K | $88.80 | $512K |
| Mar 5, 25 | Percy H. CarterCHIEF SCIENTIFIC OFFICER | SELL | 3.5K | $88.80 | $313K |
| Mar 5, 25 | Debra Durso-bumpusCHIEF PEOPLE OFFICER | SELL | 5.2K | $88.80 | $458K |
| Mar 5, 25 | Kate HavilandCHIEF EXECUTIVE OFFICER | SELL | 16.2K | $88.80 | $1.4M |
| Mar 5, 25 | L. Becker HewesCHIEF MEDICAL OFFICER | SELL | 4.9K | $88.80 | $432K |
| Mar 5, 25 | Ariel HurleyPRINCIPAL ACCOUNTING OFFICER | SELL | 1.3K | $88.80 | $118K |
| Mar 5, 25 | Michael LandsittelCHIEF FINANCIAL OFFICER | SELL | 5.3K | $88.80 | $469K |
| Mar 5, 25 | Philina LeeCHIEF COMMERCIAL OFFICER | SELL | 3.7K | $88.80 | $331K |
| Mar 5, 25 | Tracey L McCainEVP AND CHIEF LEGAL OFFICER | SELL | 5.3K | $88.80 | $467K |
| Mar 5, 25 | Fouad NamouniPRESIDENT, R & D | SELL | 6.5K | $88.80 | $576K |
| Mar 5, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 6.5K | $88.80 | $577K |
| Mar 3, 25 | Ariel HurleyPRINCIPAL ACCOUNTING OFFICER | SELL | 1.1K | $95.16 | $102K |
| Feb 20, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 2.3K | $95.14 | $216K |
| Jan 21, 25 | Jeffrey W. AlbersDirector | SELL | 7.6K | $110.61 | $825K |
| Jan 21, 25 | Kate HavilandCHIEF EXECUTIVE OFFICER | SELL | 1.4K | $110.24 | $159K |
| Jan 21, 25 | Christina RossiCHIEF OPERATING OFFICER | SELL | 816 | $111.81 | $90K |
| Jan 13, 25 | Jeffrey W. AlbersDirector | SELL | 5.0K | $102.28 | $511K |
| Jan 13, 25 | Ariel HurleyPRINCIPAL ACCOUNTING OFFICER | SELL | 2.3K | $100.00 | $225K |
| Dec 19, 24 | Jeffrey W. AlbersDirector | SELL | 5.2K | $91.96 | $461K |
| Dec 18, 24 | Christina RossiCHIEF OPERATING OFFICER | SELL | 2.2K | $96.50 | $208K |
| Dec 12, 24 | Ariel HurleyPRINCIPAL ACCOUNTING OFFICER | SELL | 1.2K | $93.99 | $111K |
| Nov 29, 24 | Kate HavilandCHIEF EXECUTIVE OFFICER | SELL | 1.7K | $97.76 | $169K |
| Nov 27, 24 | Christina RossiCHIEF OPERATING OFFICER | SELL | 2.3K | $95.10 | $216K |
| Nov 21, 24 | Lonnel CoatsDirector | SELL | 9.8K | $94.87 | $932K |
| Nov 20, 24 | Lonnel CoatsDirector | SELL | 5.3K | $94.99 | $498K |
| Nov 7, 24 | Jeffrey W. AlbersDirector | SELL | 5.0K | $102.00 | $510K |
| Oct 3, 24 | Fouad NamouniPRESIDENT, R & D | SELL | 3.6K | $89.32 | $325K |
| Sep 9, 24 | Jeffrey W. AlbersDirector | SELL | 12.0K | $85.86 | $1.0M |
| Aug 15, 24 | Michael LandsittelCHIEF FINANCIAL OFFICER | SELL | 4.4K | $95.23 | $420K |
| Aug 5, 24 | Philina LeeCHIEF COMMERCIAL OFFICER | SELL | 41.9K | $93.19 | $3.9M |
| Jul 5, 24 | Debra Durso-bumpusCHIEF PEOPLE OFFICER | SELL | 3.9K | $111.20 | $428K |
| Jul 3, 24 | Debra Durso-bumpusCHIEF PEOPLE OFFICER | SELL | 8.8K | $111.29 | $981K |
| Jun 28, 24 | Debra Durso-bumpusCHIEF PEOPLE OFFICER | SELL | 333 | $111.15 | $37K |
| Jun 21, 24 | Debra Durso-bumpusCHIEF PEOPLE OFFICER | SELL | 40.4K | $105.82 | $4.2M |
| Jun 5, 24 | Percy H. CarterCHIEF SCIENTIFIC OFFICER | SELL | 4.0K | $105.13 | $421K |
| Jun 4, 24 | L. Becker HewesCHIEF MEDICAL OFFICER | SELL | 2.4K | $104.91 | $254K |
| Jun 3, 24 | Percy H. CarterCHIEF SCIENTIFIC OFFICER | SELL | 2.4K | $106.43 | $259K |
| Jun 3, 24 | L. Becker HewesCHIEF MEDICAL OFFICER | SELL | 3.0K | $106.43 | $316K |
| May 31, 24 | L. Becker HewesCHIEF MEDICAL OFFICER | SELL | 20.9K | $107.86 | $2.2M |
Over the past 12 months, insiders at Blueprint Medicines Corp filed 0 open-market purchases worth $0 and 0 sales worth $0 on BPMC, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at Blueprint Medicines Corp filed open-market SEC Form 4 transactions on BPMC over the last 12 months.
InsiderTape plots every BPMC insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Blueprint Medicines Corp insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →